114 related articles for article (PubMed ID: 19275755)
1. The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer.
Christov K
Curr Cancer Drug Targets; 2009 Mar; 9(2):142-7. PubMed ID: 19275755
[TBL] [Abstract][Full Text] [Related]
2. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
3. Early in vitro passages of breast cancer cells are differentially susceptible to retinoids and differentially express RARβ isoforms.
Peng X; Green A; Shilkaitis A; Zhu Y; Bratescu L; Christov K
Int J Oncol; 2011 Sep; 39(3):577-83. PubMed ID: 21667021
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
5. Downstream codons in the retinoic acid receptor beta -2 and beta -4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription.
Chen LI; Sommer KM; Swisshelm K
J Biol Chem; 2002 Sep; 277(38):35411-21. PubMed ID: 12118004
[TBL] [Abstract][Full Text] [Related]
6. Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapy.
Swift CB; Hays JL; Petty WJ
Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):47-50. PubMed ID: 18393922
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells.
Peng X; Mehta RG; Tonetti DA; Christov K
Oncogene; 2005 Feb; 24(7):1296-301. PubMed ID: 15558014
[TBL] [Abstract][Full Text] [Related]
9. Retinoid, retinoic acid receptor beta and breast cancer.
Yang Q; Sakurai T; Kakudo K
Breast Cancer Res Treat; 2002 Nov; 76(2):167-73. PubMed ID: 12452454
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
11. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
[TBL] [Abstract][Full Text] [Related]
12. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
[TBL] [Abstract][Full Text] [Related]
13. Retinoids and breast cancer: new clues to increase their activity and selectivity.
Garattini E; Paroni G; Terao M
Breast Cancer Res; 2012 Sep; 14(5):111. PubMed ID: 22992337
[TBL] [Abstract][Full Text] [Related]
14. Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review).
Shilkaitis A; Green A; Christov K
Int J Oncol; 2015 Jul; 47(1):35-42. PubMed ID: 25997921
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of retinoic acid receptor-alpha specific amides.
Beard RL; Duong TT; Teng M; Klein ES; Standevan AM; Chandraratna RA
Bioorg Med Chem Lett; 2002 Nov; 12(21):3145-8. PubMed ID: 12372520
[TBL] [Abstract][Full Text] [Related]
17. Nuclear retinoic acid receptor beta as a tool in chemoprevention trials.
Pavan B; Biondi C; Dalpiaz A
Curr Med Chem; 2006; 13(29):3553-63. PubMed ID: 17168722
[TBL] [Abstract][Full Text] [Related]
18. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
Fanjul AN; Bouterfa H; Dawson M; Pfahl M
Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
20. Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression.
Peng X; Wood S; Bratescu L; Shilkaitis A; Christov K
Cancer Lett; 2005 May; 222(2):153-63. PubMed ID: 15863264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
